# Decrypting Variants of Uncertain Significance in Long-QT Syndrome

> **NIH NIH R01** · NORTHWESTERN UNIVERSITY · 2021 · $31,592

## Abstract

Genetic testing has become standard-of-care for many heritable diseases including congenital long-
QT syndrome (LQTS). However, interpreting genetic test results is often confounded by the discovery
of ‘variants of unknown significance’ (VUS) for which there is insufficient data to determine whether a
particular variant is benign or pathogenic. The emergence of widespread clinical genetic testing and
the use of next-generation sequencing in research have caused explosive growth in the number of
known variants associated with disease traits and in populations. The goal of this project is to develop
a novel paradigm for distinguishing disease-causing mutations from benign variants in LQTS and
related genetic arrhythmia syndromes. We will focus on two potassium channel subunit genes,
KCNQ1 and KCNE1, which are associated with LQTS, short-QT syndrome and familial atrial
fibrillation. The ability to discern reliably whether a variant is a true risk factor would be transformative,
improving patient care by avoiding unnecessary or potentially harmful interventions in carriers of
benign variants, guiding therapy of true mutation carriers and improving family counseling.
During the prior period of support, we implemented and optimized a high throughput experimental
strategy to determine the functional consequences of ~110 KCNQ1 variants located in the KCNQ1
voltage-sensing domain (VSD) (Aim 1). In parallel, we elucidated the stability, structural properties,
and cell surface expression of ~50 KCNQ1 VSD variants and deduced a previously unrecognized
functional domain in the channel (S0 segment; Aim 2). Using data from the literature and from Aims
1-2, we developed, trained and tested a computational predictor for estimating the likelihood of
channel dysfunction caused by KCNQ1 variants that performs better than other variant prediction
algorithms (Aim 3). Together our work provides a new paradigm for addressing the emerging
challenge of genetic variant classification. In the next funding period, we propose to continue this
novel multidisciplinary paradigm to evaluate ~200 additional KCNQ1 variants at the functional and
structural levels with an emphasis on variants in the pore domain and C-terminus, to investigate the
functional and structural consequences of all known KCNE1 variants (~110), examine the impact of
KCNQ1 and KCNE1 variants on intersubunit binding, and to develop an advanced computational
pathogenicity predictor. Our study will yield a large and unprecedented database of functional,
structural and biochemical properties of hundreds of KCNQ1 and KCNE1 variants along with an
advanced, data-trained computational prediction algorithm capable of accurately discriminating
deleterious from benign variants. These results will contribute to improving the accuracy of LQTS
genetic test interpretation and improve medical decision-making for LQTS.

## Key facts

- **NIH application ID:** 10455866
- **Project number:** 3R01HL122010-08S1
- **Recipient organization:** NORTHWESTERN UNIVERSITY
- **Principal Investigator:** Alfred L. George
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $31,592
- **Award type:** 3
- **Project period:** 2014-08-01 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10455866

## Citation

> US National Institutes of Health, RePORTER application 10455866, Decrypting Variants of Uncertain Significance in Long-QT Syndrome (3R01HL122010-08S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10455866. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*